These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11834236)
1. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women. Massai MR; Díaz S; Quinteros E; Reyes MV; Herreros C; Zepeda A; Croxatto HB; Moo-Young AJ Contraception; 2001 Dec; 64(6):369-76. PubMed ID: 11834236 [TBL] [Abstract][Full Text] [Related]
2. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women. Coutinho EM; Athayde C; Dantas C; Hirsch C; Barbosa I Contraception; 1999 Feb; 59(2):115-22. PubMed ID: 10361626 [TBL] [Abstract][Full Text] [Related]
3. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices. Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703 [TBL] [Abstract][Full Text] [Related]
4. Parenteral administration of progestin Nestorone to lactating cynomolgus monkeys: an ideal hormonal contraceptive at lactation? Heikinheimo O; Ranta S; Moo-Young A; Lähteenmäki P; Gordon K Hum Reprod; 1999 Aug; 14(8):1993-7. PubMed ID: 10438416 [TBL] [Abstract][Full Text] [Related]
5. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation. Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061 [TBL] [Abstract][Full Text] [Related]
7. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women. Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447 [TBL] [Abstract][Full Text] [Related]
8. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454 [TBL] [Abstract][Full Text] [Related]
9. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Fraser IS; Weisberg E; Minehan E; Johansson ED Contraception; 2000 Apr; 61(4):241-51. PubMed ID: 10899479 [TBL] [Abstract][Full Text] [Related]
10. New IPPF statement on breastfeeding, fertility and post-partum contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285 [TBL] [Abstract][Full Text] [Related]
11. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women. Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396 [TBL] [Abstract][Full Text] [Related]
12. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects. Laurikka-Routti M; Haukkamaa M Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263 [TBL] [Abstract][Full Text] [Related]
13. Contraceptive implants and lactation. Díaz S Contraception; 2002 Jan; 65(1):39-46. PubMed ID: 11861054 [TBL] [Abstract][Full Text] [Related]
14. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292 [TBL] [Abstract][Full Text] [Related]
15. Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women. Sivin I; Croxatto H; Bahamondes L; Brache V; Alvarez F; Massai R; Schechter J; Ranta S; Kumar N; Wu E; Tejeda AS; Reyes V; Travers E; Allen A; Moo-Young A Contraception; 2004 Feb; 69(2):137-44. PubMed ID: 14759619 [TBL] [Abstract][Full Text] [Related]
16. Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus. Short RV; Lewis PR; Renfree MB; Shaw G Lancet; 1991 Mar; 337(8743):715-7. PubMed ID: 1672186 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Shaamash AH; Sayed GH; Hussien MM; Shaaban MM Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660 [TBL] [Abstract][Full Text] [Related]
19. Ovarian function during use of Nestorone(R) subdermal implants. Brache V; Massai R; Mishell DR; Moo-Young AJ; Alvarez F; Salvatierra AM; Cochon L; Croxatto H; Robbins A; Faundes A Contraception; 2000 Mar; 61(3):199-204. PubMed ID: 10827334 [TBL] [Abstract][Full Text] [Related]
20. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth. Peralta O; Díaz S; Juez G; Herreros C; Casado ME; Salvatierra AM; Miranda P; Durán E; Croxatto HB Contraception; 1983 Jan; 27(1):27-38. PubMed ID: 6404597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]